SGLT2 Inhibitors: Basic Training Quiz

The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.


Hospital staff or other physicians would never consider changing a chemo or dialysis order. But when it comes to insulin, its open season. This needs to stop.

Early results also found an inverse relationship between serum CT levels and estimated glomerular filtration rate.

Not all patients with type 2 diabetes respond equally to GLP-1 receptor agonists. Results of a recent study suggest what to look for before you write that next Rx.

New endocrinology drugs

Since June of 2014, the US FDA has approved a number of drugs for a variety of endocrine-related diseases. Here are 10 of them.

While we are increasingly evaluated on numbers—A1c, blood pressure, LDL—these parameters are largely outside of our direct control. Mr M is a case in point.

There are pros and cons to using SGLT2 inhibitors in the elderly. Are you familiar with both? Find out with 7 quick multiple choice questions.

John is an active older man whose A1c has gone from 6.8% to 7.6% since his last follow-up visit. He refuses to get involved in any “needle business.” What’s next?


Subscribe to Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.